medicare glp 1 GLP-1 Drug Coverage Medicare GLP-1 Bridge: Who Qualifies

While Medicare currently is prohibited by statute from covering weight-loss-only medications, the Center for Medicare and Medicaid Innovation has the authority to design and test new payment models that lower program spending while maintaining or improving the quality of care

doi: 10.1016/S0140-6736(21)01443-4 [DOI] [PubMed] [Google Scholar] 193.Del Prato S, Kahn SE, Pavo I, et al

This staggering statistic highlights the increasing prevalence of weight-related issues and the urgent need for effective solutions

Research shows that lifestyle habits amplify the benefits of these drugs and help sustain results over time

And the world has never needed these drugs more

Preclinical studies have suggested that GLP-1 receptors are expressed in thyroid tissue, and animal models have indicated possible anti-inflammatory effects that could theoretically influence autoimmune processes